Universe · entity
Opaleye Management Inc.
Institutional manager (13F) · CIK 1595855
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $758M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | HARROW INC | $100M | 2,832,230 |
| 2 | LIQUIDIA CORPORATION | $89M | 2,545,000 |
| 3 | ETON PHARMACEUTICALS INC | $71M | 2,860,000 |
| 4 | SOL-GEL TECHNOLOGIES LTD | $40M | 500,000 |
| 5 | RHYTHM PHARMACEUTICALS INC | $35M | 123,000 |
| 6 | APOGEE THERAPEUTICS INC | $33M | 390,000 |
| 7 | DISC MEDICINE INC | $27M | 421,000 |
| 8 | UROGEN PHARMA LTD | $26M | 1,430,000 |
| 9 | CRESCENT BIOPHARMA INC. | $24M | 1,312,615 |
| 10 | STOKE THERAPEUTICS INC | $23M | 700,000 |
| 11 | PERSPECTIVE THERAPEUTICS INC | $19M | 4,675,000 |
| 12 | REZOLUTE INC | $19M | 6,300,000 |
| 13 | MEIRAGTX HLDGS PLC | $18M | 2,123,259 |
| 14 | TG THERAPEUTICS INC | $18M | 535,000 |
| 15 | SANUWAVE HEALTH INC | $17M | 981,267 |
| 16 | EDGEWISE THERAPEUTICS INC | $16M | 500,000 |
| 17 | ALPHA COGNITION INC | $14M | 2,561,950 |
| 18 | ANNEXON INC | $13M | 2,331,761 |
| 19 | ALUMIS INC | $12M | 550,000 |
| 20 | CODEXIS INC | $11M | 6,785,000 |
| 21 | PROTAGONIST THERAPEUTICS INC | $11M | 100,000 |
| 22 | REVOLUTION MEDICINES INC | $10M | 100,000 |
| 23 | XOMA ROYALTY CORPORATION | $9M | 300,000 |
| 24 | Q32 BIO INC | $8M | 1,256,228 |
| 25 | MBX BIOSCIENCES INC | $8M | 260,000 |
| 26 | RELMADA THERAPEUTICS INC | $7M | 935,000 |
| 27 | CG ONCOLOGY INC | $6M | 94,800 |
| 28 | JADE BIOSCIENCES INC | $6M | 427,608 |
| 29 | OCULAR THERAPEUTIX INC | $5M | 600,000 |
| 30 | ASSERTIO HOLDINGS INC | $5M | 265,707 |
| 31 | EDITAS MEDICINE INC | $5M | 1,926,997 |
| 32 | SUTRO BIOPHARMA INC | $5M | 190,671 |
| 33 | JOURNEY MED CORP | $5M | 960,000 |
| 34 | VOYAGER THERAPEUTICS INC | $4M | 1,150,000 |
| 35 | TREVI THERAPEUTICS INC | $4M | 345,100 |
| 36 | TECTONIC THERAPEUTIC INC | $4M | 123,000 |
| 37 | CABALETTA BIO INC | $4M | 1,380,000 |
| 38 | BIODESIX INC | $3M | 238,047 |
| 39 | ROCKET PHARMACEUTICALS INC | $3M | 955,000 |
| 40 | ZENTALIS PHARMACEUTICALS INC | $3M | 1,412,656 |
| 41 | INTELLIA THERAPEUTICS INC | $3M | 245,000 |
| 42 | FORTRESS BIOTECH INC | $3M | 1,042,000 |
| 43 | OPUS GENETICS INC | $2M | 1,120,000 |
| 44 | RIGEL PHARMACEUTICALS INC | $2M | 70,000 |
| 45 | ATEA PHARMACEUTICALS INC | $2M | 322,600 |
| 46 | LYELL IMMUNOPHARMA INC | $2M | 79,097 |
| 47 | ENANTA PHARMACEUTICALS INC | $2M | 125,000 |
| 48 | NEXTCURE INC | $2M | 141,181 |
| 49 | 4D MOLECULAR THERAPEUTICS IN | $1M | 112,291 |
| 50 | PERSPECTIVE THERAPEUTICS INC | $834k | 200,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.